DV
Dividend Vision

PFSA Stock — Profusa, Inc. Common Stock

Profusa, Inc. Common Stock (PFSA)

Updated October 16, 2026.

PFSA is a Stock. Total return is -90.4% over the past 4.7 years, 175.3 points behind SPY at 84.9%.

Profusa is a digital health technology company based in Berkeley, California that develops bioengineered sensors designed to detect and continuously transmit clinical-grade data from the body. The company's current offering is the Lumee Oxygen Platform for monitoring compromised tissue in conditions such as peripheral artery disease, chronic wounds, and reconstructive surgery, while it continues to research and develop the Lumee Glucose Platform for glucose monitoring. The company does not currently distribute dividends.

PFSA performance versus SPY

Price and return data through 2026-10-16.

Total return is -90.4% over the past 4.7 years, 175.3 points behind SPY at 84.9%. Over the past year its total return — price change plus distributions reinvested — is -99.8%. Its deepest 1-year drawdown was 99.8%.

WindowTotal returnCAGR
1M-47.7%—
3M-49.9%—
6M-94.2%—
YTD-99.5%—
1Y-99.8%—
2Y CAGR—-71.80%
3Y CAGR—-55.80%
Since inception (4.7 years)-90.4%-39.10%

PFSA key facts

Asset type
Stock
Asset class
Equity
Inception date
01/24/2022
Distribution frequency
None
Last close
$0.93 (as of 2026-10-16)
Market cap
$563,918
Average volume
128967.0
Beta
0.497
Payout ratio
0.0%
EPS
$872.68

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PFSA risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 99.8%.

Who may consider PFSA — and who may not

It is a weaker fit for investors who need monthly cash flow (PFSA does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on PFSA

Tagged: Healthcare.

Frequently asked questions

Does PFSA pay monthly?

No. PFSA does not currently distribute.

When does PFSA pay a dividend?

PFSA does not currently distribute.

How has PFSA performed?

Total return is -90.4% over the past 4.7 years, 175.3 points behind SPY at 84.9%. Over the past year its total return — price change plus distributions reinvested — is -99.8%. Its deepest 1-year drawdown was 99.8%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.